Drug Shortage Report for CANDESARTAN/HCTZ
Report ID | 225881 |
Drug Identification Number | 02394804 |
Brand name | CANDESARTAN/HCTZ |
Common or Proper name | CANDESARTAN/HCTZ |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL |
Strength(s) | 12.5MG 16MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-04-22 |
Estimated end date | 2024-08-16 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-04-23 | English | Compare |
v2 | 2024-04-22 | French | Compare |
v1 | 2024-04-22 | English | Compare |
Showing 1 to 3 of 3